Verapamil	verapamil	S_chemicals	O
withdrawal	withdrawal	O	O
as	as	O	O
a	a	O	O
possible	possible	O	O
cause	cause	O	O
of	of	O	O
myocardial	myocardial	O	B_disease
infarction	infarction	O	S_disease
in	in	O	O
a	a	O	O
hypertensive	hypertensive	O	O
woman	woman	O	O
with	with	O	O
a	a	O	O
normal	normal	O	O
coronary	coronary	O	O
angiogram	angiogram	O	O
.	.	O	O

Verapamil	verapamil	S_chemicals	O
is	is	O	O
an	an	O	O
effective	effective	O	O
and	and	O	O
relatively-safe	relatively-safe	O	O
antihypertensive	antihypertensive	B_chemicals	O
drug	drug	S_chemicals	O
.	.	O	O

Serious	serious	O	O
adverse	adverse	O	B_disease
effects	effects	O	I_disease
are	are	O	O
uncommon	uncommon	O	O
and	and	O	O
mainly	mainly	O	O
have	have	O	O
been	been	O	O
related	related	O	O
to	to	O	O
the	the	O	O
depression	depression	O	O
of	of	O	O
cardiac	cardiac	O	O
contractility	contractility	O	O
and	and	O	O
conduction	conduction	O	O
,	,	O	O
especially	especially	O	O
when	when	O	O
the	the	O	O
drug	drug	S_chemicals	O
is	is	O	O
combined	combined	O	O
with	with	O	O
beta-blocking	beta-blocking	O	O
agents	agents	O	O
.	.	O	O

We	we	O	O
report	report	O	O
a	a	O	O
case	case	O	O
in	in	O	O
which	which	O	O
myocardial	myocardial	O	B_disease
infarction	infarction	O	S_disease
coincided	coincided	O	O
with	with	O	O
the	the	O	O
introduction	introduction	O	O
of	of	O	O
captopril	captopril	S_chemicals	O
and	and	O	O
the	the	O	O
withdrawal	withdrawal	O	O
of	of	O	O
verapamil	verapamil	S_chemicals	O
in	in	O	O
a	a	O	O
previously	previously	O	O
asymptomatic	asymptomatic	O	O
woman	woman	O	O
with	with	O	O
severe	severe	O	O
hypertension	hypertension	O	S_disease
.	.	O	O

Possible	possible	O	O
mechanisms	mechanisms	O	O
that	that	O	O
involve	involve	O	O
a	a	O	O
verapamil-related	verapamil-related	O	O
increase	increase	O	O
in	in	O	O
platelet	platelet	O	O
and/or	and/or	O	O
vascular	vascular	O	O
alpha	alpha	O	O
2-adrenoreceptor	2-adrenoreceptor	O	O
affinity	affinity	O	O
for	for	O	O
catecholamines	catecholamines	S_chemicals	O
are	are	O	O
discussed	discussed	O	O
.	.	O	O

